The Cost of Operating Sexual Health Clinics During the Ending the (HIV) Epidemic Initiative in New York City. Issue 11 (11th November 2022)

• Record Type: Journal Article
• Authors: Williams, Austin M.; Jamison, Kelly; Eppink, Samuel T.; Pathela, Preeti; Blank, Susan; Peters, Dana; Gift, Thomas L.; Berruti, Andrés A.
• Is Part Of: Sexually transmitted diseases. Volume 49:Issue 11(2022)
• Page Start: 771
• Page End: 777
• Publication Date: 2022-11-11
• Subjects: Sexually transmitted diseases -- Periodicals; Sexual health -- Periodicals; 616.951005
• DOI: 10.1097/OLQ.0000000000001691
• Languages: English
• ISSNs: 0148-5717

Abstract

Abstract : When sexual health clinics in New York City began offering enhanced HIV services, increases in overall and per-visit costs were mostly attributable to additional personnel and dispenses of HIV-related medications. Abstract : Background: As part of New York State's Ending the Epidemic (EtE) initiative, sexual health clinics (SHCs) in New York City invested in clinic enhancements and expanded their HIV-related services to increase access to HIV prevention interventions and treatment. The objective of this study was to estimate and describe the change in SHC operating costs related to clinic enhancements and expanded patient services implemented as part of the EtE initiative. Methods: A comprehensive microcosting approach was used to collect retrospective cost information from SHCs, broken down by category and programmatic activity. Cost information was collected from 8 clinics across New York City during two 6-month time periods before (2015) and during (2018–2019) EtE. Results: Eight SHCs reported comprehensive cost data. Costs increased by $800, 000 on average per clinic during the 6-month EtE period. The cost per visit at an SHC increased by $120 on average to $381 (ranging from $302 to $464) during the EtE period. Personnel costs accounted for 69.9% of EtE costs, and HIV-related medications accounted for 8.9% of costs. Employment of social workers and patient navigators increased costs by approximately $150, 000 on average per clinic. Postexposure prophylaxis was the costliest medication with average expenditures of $103, 800 per clinic. Conclusions: This study demonstrates the key drivers of cost increases when offering enhanced HIV services in SHCs. Documenting the changes in resources necessary to implement these services and their costs can inform other health departments on the viability of offering enhanced HIV services within their own clinics.